Share on StockTwits
 

Thermo Fisher Scientific (NYSE:TMO) CEO Marc N. Casper sold 208,765 shares of Thermo Fisher Scientific stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $115.70, for a total value of $24,154,110.50. Following the completion of the transaction, the chief executive officer now directly owns 229,730 shares in the company, valued at approximately $26,579,761. The sale was disclosed in a document filed with the SEC, which is available at this link.

A number of analysts have recently weighed in on TMO shares. Analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note to investors on Tuesday, February 4th. They now have a $121.00 price target on the stock. Separately, analysts at Leerink Swann raised their price target on shares of Thermo Fisher Scientific from $107.00 to $130.00 in a research note to investors on Friday, January 31st. They now have an “outperform” rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Thermo Fisher Scientific from $128.00 to $136.00 in a research note to investors on Friday, January 31st. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $110.93.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded up 0.71% on Monday, hitting $118.61. 4,233,031 shares of the company’s stock traded hands. Thermo Fisher Scientific has a 52 week low of $71.60 and a 52 week high of $119.00. The stock’s 50-day moving average is $112.9 and its 200-day moving average is $99.52. The company has a market cap of $42.913 billion and a price-to-earnings ratio of 33.80.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.05. The company had revenue of $3.47 billion for the quarter, compared to the consensus estimate of $3.31 billion. On average, analysts predict that Thermo Fisher Scientific will post $6.80 earnings per share for the current fiscal year.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.